Kimberly-Clark Corporation (KMB) Stock Price & Analysis
Kimberly-Clark Corporation (KMB) — MoonshotScore 79/100 (Strong band), calculated Nov 18, 2026. Price $105.25 (-1.86%), as of the Nov 19, 2026 trading session; market cap $64.6B. Expected results Jan 26, 2027.
Listing-status flag — 8-K Item 3.01, filed May 19, 2025.
Educational signal · not a buy or sell recommendation · How to read this
Kimberly-Clark Corporation · KMB · NASDAQ · Consumer Defensive · Household & Personal Products
Research dated 2026-09-12: Kimberly-Clark sells branded diapers, adult and feminine care, consumer tissue, and professional hygiene products through retailers, distributors, facilities, and e-commerce. Diapers carry the largest product exposure, so this is not merely a tissue company. Steady cash generation now has to offset a sharp annual sales contraction, profit pressure below gross profit, and debt far above liquid resources.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Kimberly-Clark (KMB)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality, but weak growth and a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Full; Growth Durability: Fading; Momentum: Rising.
- quarterly revenue $4.15B (Q3 FY2025, quarter ended Sep 2025)
- EPS beat 0 of the last 4 reports
- expected results Jan 26, 2027
Holding back: soft growth
Helping: business quality, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 72 | Strong | |
| 73 | Strong | |
| 73 | Strong | |
| 79 | Strong | |
| 79 | Strong | |
| 79 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $105.25 | |
| Change on the day | -1.86% | |
| 52-week range | $92.42–$116.82 | |
| Market capitalisation | $64.6B | — |
| Price / earnings (trailing) | 10.89 | |
| Shares traded on the day | 7.23M | |
| Beta (volatility vs the S&P 500) | 0.28 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Kimberly-Clark (KMB): perspectives
Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 20, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
One of these lenses reads this company less favourably than the MoonshotScore does: Financial health lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Kimberly-Clark (KMB), and what does it report?
Short answer · as of
The economic engine is repeated replenishment of Huggies, Pull-Ups, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, and related products.
Research dated 2026-09-12.
Household purchases flow through retailers and e-commerce, while professional products reach manufacturers, lodging operators, offices, food-service sites, and public facilities.
Operational reporting separates North America from International Personal Care, while the product view separates diapers, adult care, feminine care, consumer tissue, and professional products. North America contains personal care alongside tissue and professional hygiene; the international operation is concentrated on personal care.
What do the latest results show for Kimberly-Clark (KMB)?
Short answer · as of
The most recent reported quarter, Q3 FY2025, carried revenue of $4.15B.
Research dated 2026-09-12.
Revenue edged higher from the preceding period and the comparable period, while gross profit also improved. That progress did not reach the bottom line: selling and administrative expense increased, operating profit weakened, and net income and diluted earnings fell sharply.
The latest release missed consensus for revenue and earnings after earnings had repeatedly exceeded expectations. The observable pressure sits below gross profit, but the results alone do not establish why those costs rose.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2025 | $4.15B | $446M | $1.34 (diluted) |
| Q4 FY2025 | $4.08B | $499M | $1.50 (diluted) |
| Q1 FY2026 | $4.16B | $665M | $2.00 (diluted) |
| Q2 FY2026 | $4.19B | $345M | $1.04 (diluted) |
What are the financial strengths and risks for Kimberly-Clark (KMB)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12.
Operating cash flow remained positive throughout the reported quarterly series and generally covered capital spending with room left over. The latest period also rebuilt cash and short-term investments substantially, although the closing balance remained below the beginning of the reported window.
Debt stands far above cash and investments, liabilities are substantial, and short-term liquidity ratios remain below full coverage. Regular dividend payments and capital investment therefore compete with debt obligations for the cash generated by everyday product sales.
Profitability and distress screens remain supportive, but elevated leverage makes continued cash conversion more important than the unusually high return on equity might imply.
What should you watch next at Kimberly-Clark (KMB)?
Short answer · as of
The next earnings report is expected on Jan 26, 2027.
Research dated 2026-09-12.
At the scheduled earnings release, watch whether sales remain near their recent quarterly range and whether improving gross profit can again reach operating profit. Selling and administrative expense is the immediate bridge between those lines, while another consensus miss would reinforce the break from the earlier earnings pattern.
Cash conversion also deserves attention: operating cash flow relative to capital spending, the direction of liquid resources, and any reduction in the gap between debt and cash. The distant consensus series contains an abrupt revenue reset far above the recent annual run rate, which becomes meaningful only if reported segment sales establish the change.
Any formal update tied to the continued-listing rule notice warrants attention alongside the periodic filings.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The newest quarter held here (Q3 FY2025) was filed Oct 30, 2025 — 12 months ago.
Checked against the records this page reads, on the dates shown above.
How does Kimberly-Clark compare with its peers?
Short answer
Kimberly-Clark's score ranks 9th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Kimberly-Clark combines recurring personal-care purchases with consumer tissue and a professional hygiene channel. A tissue-only comparison misses the largest product exposure, while a personal-care-only comparison leaves out household paper products and demand from workplaces, lodging, food service, manufacturing, and public facilities.
The reporting structure also matters: North America carries the broader portfolio, whereas the international segment centers on personal care. Regional performance therefore reflects a different product mix rather than merely the same portfolio sold in different places.
| Company | Price | Market value | Score |
|---|---|---|---|
| $132.94 Nov 19, 2026 | $4.26B | 96 5-pillar Nov 18, 2026 | |
| $2.66 Nov 19, 2026 | $41.0B | 94 5-pillar Nov 18, 2026 | |
| $96.88 Nov 19, 2026 | $77.0B | 93 5-pillar Nov 18, 2026 | |
| $63.36 Nov 19, 2026 | $136B | 88 5-pillar Nov 18, 2026 | |
| $167.85 Nov 19, 2026 | $389B | 88 5-pillar Nov 18, 2026 | |
| $174.05 Nov 19, 2026 | $35.0B | 86 5-pillar Nov 18, 2026 | |
| $108.93 Nov 19, 2026 | $6.44B | 84 5-pillar Nov 18, 2026 | |
| $109.68 Nov 19, 2026 | $25.9B | 82 5-pillar Nov 18, 2026 | |
| Kimberly-Clark (KMB) — this page | $105.25 | $64.6B | 79 |
| $101.77 Nov 19, 2026 | $36.9B | 64 5-pillar Nov 18, 2026 | |
| $104.90 Nov 19, 2026 | $12.7B | 60 5-pillar Nov 18, 2026 | |
| $59.44 Nov 19, 2026 | $13.7B | 58 5-pillar Nov 18, 2026 | |
| $11.86 Nov 19, 2026 | $12.7B | 57 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
- $105.00 – $120.00
- Last captured analyst target (expired, captured Nov 18, 2026)
- $114.20
- Last captured median analyst target (expired, captured Nov 18, 2026)
- $115.00
Historical target record · Captured · Capture expired; not a current watchpoint.
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 2, 2026
- Transactions
- 22
- Identified insiders
- 10
- Purchases
- 0
- Sales
- 0
- Other transactions
- 22
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held KMB in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported KMB in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Kimberly-Clark (KMB)?
KMB Consumer Defensive Stock FAQ
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Why do Huggies and adult-care products matter to Kimberly-Clark?
Diapers generate more revenue than any other disclosed product category, while adult care adds a distinct replenishment market through Depend, Poise, and related brands.
Why can stronger Kleenex and tissue economics fail to lift Kimberly-Clark operating profit?
Gross profit improved in the latest period, but higher selling and administrative expense coincided with weaker operating profit and net income. Improvement at the product margin level must survive the cost structure below it.
What does International Personal Care include at Kimberly-Clark?
The segment sells baby and child care, adult care, and feminine care products under brands including Huggies, Kotex, Depend, Goodfeel, and Intimus. Consumer tissue and professional hygiene sit within the broader North American operation.
Can Kimberly-Clark support its dividend while carrying substantial debt?
Recent operating cash flow has covered capital spending, and dividend payments have remained regular. Debt remains far above liquid resources, so continued cash conversion is central to preserving that flexibility.
What is the KMB stock price today?
The last price recorded for Kimberly-Clark Corporation (KMB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the KMB price target?
The last analyst consensus price target we captured for Kimberly-Clark Corporation (KMB), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 26 figures on this page — 2 from SEC filings and earnings calls, 21 from Financial Modeling Prep (FMP), 2 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-12), by section of the research
ETFs that hold KMB
Funds in our ETF coverage that list KMB among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| VictoryShares Dividend Accelerator ETF (VSDA) | 2.98% | |
| Xtrackers S&P Dividend Aristocrats Screened ETF (SNPD) | 1.99% |